Lost in the Crossfire: Why Zimbabwe's Medical Services Amendment Bill Must Put Patients First

The debate surrounding Zimbabwe's Medical Services Amendment Bill has reached a critical juncture. Unfortunately, the discussion is increasingly defined by corporate friction, regulatory disputes, and competing commercial interests rather than a shared vision for improving healthcare outcomes.

As medical aid funders and healthcare providers clash over the provisions of the proposed law, the conversation has become consumed by questions of revenue streams, ownership structures, market dominance, tariffs, and regulatory control. In the process, the patient, the very person the healthcare system is supposed to serve, has been pushed to the margins of the debate. Both medical aid societies and healthcare providers exist, in principle, to deliver quality healthcare to patients. Yet the current discourse often sounds less like a discussion about public health and more like a battle over corporate territory.

The patient has become an afterthought. To understand how Zimbabwe arrived at this point, it is necessary to revisit the evolution of the country's private healthcare financing model. In the 1990s and early 2000s, medical aid societies increasingly moved beyond their traditional role as third-party funders and began investing directly in healthcare delivery. The establishment of provider networks such as Premier Service Medical Investments (PSMI) in 2003 emerged against a backdrop of severe economic instability.

At the time, medical aid societies faced mounting challenges. Healthcare practitioners demanded cash payments due to delayed remittances, tariff disputes were commonplace, healthcare costs were rising rapidly, and frequent public sector strikes disrupted service delivery. Vertical integration appeared to offer a practical solution. By owning hospitals, clinics, pharmacies, and laboratories, medical aid societies could guarantee that members would continue receiving care even during periods of economic turmoil.

Initially, the model served an important purpose. Over time, however, what began as a mechanism to protect patients evolved into a source of industry-wide conflict.

Independent doctors, specialists, and private healthcare facilities increasingly argue that vertically integrated medical aid societies enjoy an unfair competitive advantage. When the same organisation funds treatment, owns healthcare facilities, operates pharmacies, and controls laboratory services, critics argue that the potential for exclusionary practices becomes difficult to ignore. The Competition and Tariff Commission has on several occasions intervened in disputes involving market dominance and competition concerns. Yet despite regulatory involvement, the conflict remains largely commercial.

Healthcare providers are fighting for fair reimbursement rates and faster claim settlements. Medical aid societies are defending business models they believe improve efficiency and reduce costs for members. Both sides have legitimate concerns. But while boardrooms debate balance sheets and market share, patients continue to navigate the consequences. For many Zimbabweans, these corporate battles translate into real-life barriers to healthcare.

A patient may faithfully pay monthly medical aid contributions only to discover that their card is not accepted by a preferred doctor because of unresolved tariff disputes. Faced with limited options, they must either pay cash they cannot afford or travel elsewhere to access treatment. In such situations, patient choice, convenience, and dignity are often sacrificed.

On the other hand, healthcare providers warn that some provisions of the proposed legislation, particularly those relating to emergency treatment obligations, could place additional financial burdens on already struggling private institutions if there is no effective reimbursement mechanism. Should private facilities become financially unsustainable, the result would be fewer healthcare providers, longer waiting times, and reduced access to care.

Once again, the patient bears the consequences.

This is why the Medical Services Amendment Bill cannot become merely a legislative compromise designed to settle corporate disputes. If the final law simply balances competing commercial interests without fundamentally improving patient outcomes, it will have failed its most important test. The central question lawmakers should ask is simple: How will this legislation improve the experience, access, and well-being of the patient?

A sustainable healthcare system requires more than regulatory compliance. It requires trust between funders, providers, and patients. The legislation should therefore prioritise measures that protect patient choice, ensure fair competition, improve transparency, and guarantee the timely settlement of medical claims. Healthcare funding mechanisms must be designed to maximise actual patient care rather than institutional advantage.

Ultimately, no Act of Parliament can create goodwill. Legislation alone cannot eliminate decades of mistrust between healthcare funders and service providers. What lawmakers can do, however, is establish a framework that places the patient at the centre of every decision.

If emotion, commercial interests, and institutional pride continue to dominate the conversation, the ultimate casualty will not be the medical aid executive or the private healthcare provider.

It will be the ordinary Zimbabwean seeking treatment. The healthcare sector does not need winners and losers. It needs a system that works. And that begins by ensuring that patients are never treated as bargaining chips in battles they neither created nor control.

Medical Services Amendment Bill